View experts by name

View by service and office location

Claus Andersen


T: 020 7842 1462 (DDI)
T: 020 7583 2222

If you are having difficulty getting in touch with your contact then you can email or call 0800 923 2073

Claus is a partner in our Corporate & Commercial and Life Sciences teams. He deals with all aspects of corporate and commercial work for corporate clients, limited companies, businesses, private individuals and trade organisations.

About Claus

Claus was admitted to the High Courts of Denmark and the Copenhagen Maritime and Commercial Court in 2003. In addition, he was admitted as a solicitor in England and Wales in February 2008 and became a partner at Royds LLP in August 2011.

Claus has substantial experience in areas including company law, commercial contracts and finance, with particular emphasis on shareholders agreements, distribution agreements, general commercial contracts, the Bribery Act 2010 and the Exemption rules of the FSMA (Financial Promotion) order.


Claus is a member of the Danish Law Society.

The Legal 500 - The Clients Guide to Law Firms


Related articles

Opinion [4]
Article thumbnail

The UK-EU Trade and Cooperation Agreement

31 December 2020

After more than 4 years of debate in the UK since the referendum and after years of negotiation with the EU about, first, a withdrawal agreement and then an agreement setting out how the future trade in some areas between the EU and the UK should work, the UK-EU Trade and Cooperation Agreement was finally signed yesterday by the EU and the UK governments.

Read more..
Article thumbnail

The key issues businesses should consider before the end of the transition period

23 November 2020

With the post-Brexit transition period ending in 31 December 2020 and talks between the EU and UK about a Free Trade Agreement (“FTA”) continuing, businesses need to continue to prepare for the key challenges ahead.

Read more..
Article thumbnail

The 13th Annual European GRC and GDPR compliance conference

13 November 2020

On 9 November 2020 I had the pleasure of speaking at the 13th Annual European GRC and GDPR compliance conference hosted by Copenhagen Compliance.

Read more..
Article thumbnail

Another record investment into British Biotech

5 November 2020

The UK BioIndustry Association, BIA, has just released its investment report for the period 1 June to 31 August 2020.

Read more..
News [4]
Article thumbnail

Departure of European Medicines Agency takes 40,000 London hotel rooms with it

21 November 2017

The EU yesterday (20 November) announced that the European Medicines Agency will relocate from its Docklands home to Amsterdam when the UK leaves the EU in 2019, taking with it around 1,000 high value jobs. The move will, says Royds …

Read more..

Court agrees to deal between business and fraud investigators

26 July 2016

The Serious Fraud Office (SFO) has this month announced a second deferred prosecution agreement which will see a firm pay more than £6million for corruption and bribery offences. The deal was reached between the unnamed company and SFO officials and …

Read more..

Politicians pledge to tackle corporate corruption

27 June 2016

The Prime Minister has outlined new plans to curb corruption in business. David Cameron set out proposals for sweeping reforms to coincide with the start of an international summit and commentators claim that the measures will eclipse those previously included …

Read more..

Bribery Act expert to attend European conference

12 October 2015

A Partner from City-based solicitors Royds will be addressing a top international conference on the subject of the UK’s Bribery Act.

Read more..
Events [1]
Article thumbnail

Life after Brexit: the challenges and opportunities facing the UK’s Life Sciences sector

5 December 2018

“The life sciences industry represents one of the dominant economic sectors in the UK.
It brings significant jobs and growth to virtually every region. To retain the UK’s competitive edge in this sector, there is a requirement for sustained effort over a longer period of time”.
Professor Sir John Bell, Regius Professor of Medicine, University of Oxford and Chairman, Office for the Strategic Coordination of Health Research.

Read more..
Case Studies [1]

Negotiation, drafting and review of a contract for a new orphan drug

Long standing client from charity sector with a patient data base, came to us with the need for legal advice. It had been approached by a European Pharmaceutical, (EP). EP wanted to have access to our client’s database in order …

Read more..

View experts by name

View by service and office location